Special Session

Presidential Symposium II - EL05 - Radiopharmaceuticals Will Replace External Beam RT for Treatment of Metastasis in the Next Decade

9/15/2019
10:15 AM - 11:45 AM
Location: Room W181

Session Type: Special Session
0.00 AMA PRA Category 1 Credits™

The role of radiation therapy in metastatic disease has traditionally been palliative in nature. Innovation in external beam radiation therapy (EBRT) technique and radiopharmaceuticals (RPTs) may allow radiation to play a curative role in metastatic disease. The session will begin with a brief introduction to RPTs and their promise as treatment for metastases now and in the future. Audience perception on the capacity of RPTs to replace external beam treatment will be assessed followed by clinical case presentations where RPT use may be appropriate. Presentations on current clinical applications and data on RPTs will be followed by moderated debate from audience members on the use of EBRT vs RPT in each case scenario.

After presentations on current clinical applications and data on RPTs, attendees will breakout into small groups, each assigned one of the below cases to discuss as a group and formulate either a PRO or a Con argument. Audience volunteers will then participate in moderated debates on the use of EBRT vs RPT in each case scenario, followed by a wrap up with a tale home message.

Presentations:

Hyun Kim, MD

Washington University in Saint Louis

Disclosure:
Employment
Washington University in St. Louis: Assistant Professor: Employee

Compensation
Varian: Consultant: Honoraria: Research Grants: Speaker's Bureau: Travel Expenses

Presentation(s):

Send Email for Hyun Kim

Ana Kiess, MD, PhD

Johns Hopkins University

Presentation(s):

Send Email for Ana Kiess

John Buatti, MD, FASTRO

University of Iowa

Biography:
John M. Buatti, MD, FASTRO, Professor and Chair, Department of Radiation Oncology, University of Iowa

Dr. Buatti is Professor and the Chair of the Department of Radiation Oncology, a position that he has held with distinction since 2001 when he established an independent department at the University of Iowa Hospitals and Clinics. In 2005, he opened Iowa’s first Center of Excellence in Image Guided Radiation Therapy, which was innovative for its use of advanced 3D imaging including a 3T MR scanner and 40 slice respiratory-gated PET/CT scanner to better locate and treat tumors. As a clinician, he is a leading authority on the treatment of cranial malignancies.
He is a prolific scholar having authored or co-authored more than 220 peer-reviewed publications. He has published 24 book chapters, and more than 170 abstracts.
With a life-long commitment to improve the quality of cancer imaging he served as the first chair of the Steering Committee for the Quantitative Imaging Network (QIN) and Chair of the Clinical Trials Design and Development Working Group and was a member of the Coordinating Committee for QIN. He has served on the ASTRO Education Committee, as Co-Chair of the ASTRO IHE-RO (Integrating Health Enterprise-Radiation Oncology) and served on the ASTRO Science Council Steering Committee. He is currently chairing an ASTRO task-force on Theranostics as well as a member of the ASTRO Nominating Committee.
He is and advocate for diversity in the workplace and encourages the development of scientist-investigators through summer internships and the active recruitment of minorities. His enthusiastic devotion to education is evident in his biography.

Presentation(s):

Send Email for John Buatti


Assets

Presidential Symposium II - EL05 - Radiopharmaceuticals Will Replace External Beam RT for Treatment of Metastasis in the Next Decade



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Presidential Symposium II - EL05 - Radiopharmaceuticals Will Replace External Beam RT for Treatment of Metastasis in the Next Decade